Substantive Updates Part Four: Key Regulatory and Pricing Developments Affecting How Life Sciences Companies Bring Products to Market

Substantive Updates Part Four: Key Regulatory and Pricing Developments Affecting How Life Sciences Companies Bring Products to Market 7-2016 - July 2016
by Kendra A. Martello, Deputy Vice President, Strategic Operations at Pharmaceutical Research and Manufacturers of America (PhRMA) (Washington, DC), Gail L. Daubert, Partner at Reed Smith LLP